Videos

John Buse, MD, PhD discusses the expanding role of GLP-1 receptor agonists in treatment of cardiovascular conditions.

Christian Ruff, MD, highlights abelacimab’s potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.

Marc Bonaca, MD, PHH, FACC discussed semaglutide’s potential benefits for non-diabetic patients with peripheral artery disease.

Kaite Krell, MPH, discusses the critical role of independent pharmacies and how proposed legislation could address challenges with PBMs.

Expert emphasized the importance of mentoring pharmacy students, supporting diverse career paths, and advocating for the profession.

Panelists discuss how digital health technologies revolutionize women’s health care through telehealth, mobile apps, and remote monitoring, expanding access, personalization, and proactive medical support.

Panelists discuss how health care professionals maintain expertise in menopause management through continuous learning via medical journals, professional networks, CME programs, digital resources, and tracking emerging research and therapeutic guidelines.

Expert explores the critical importance of emotional intelligence, work-life balance, and strategic leadership in pharmacy.

Panelists discuss how health care professionals use standardized antibody-drug conjugate (ADC) pathways to guide dosing, adverse effect (AE) management, and transitions. Protocols ensure monitoring, toxicity mitigation, and seamless shifts between therapies for optimal care.

Panelists discuss how pharmacists should monitor neutropenia, diarrhea, and mucositis from sacituzumab govitecan (SG); interstitial lung disease (ILD) and neutropenia from trastuzumab deruxtecan (T-DXd); and neutropenia and ILD from datopotamab deruxtecan (Dato-DXd). Proactive management is essential for patient safety.

Community health workers improve patient care and address health care access gaps.

Helping patients adhere to their medications to manage their chronic kidney disease (CKD) and comorbidities is one of the key areas pharmacists should prioritize.

Pharmacy technicians can elevate their careers by developing leadership skills, pursuing specialized certifications, and embracing continuous professional growth.

Megan May, PharmD, BCOP, FHOPA, FAPO, discusses lurbinectedin and tarlatamab and what ongoing research in the small cell lung cancer (SCLC) space entails.

The legislation is expected to improve the financial stability of independent and community pharmacies by ensuring fair reimbursement rates and allowing them to better manage their finances.

Expert offers insights into managing stress and preventing burnout in pharmacy leadership

Automation can enhance medication management and support pharmacists' critical clinical roles.

Pharmacists are pivotal in expanding reproductive health care access through patient education and collaboration.

Pharmacists are leading the way in personalized medicine through strategic pharmacogenetic implementation.

Pharmacists can empower patient RSV vaccination through strategic communication and personalized care.

Pharmacists can navigate career paths through passion, adaptability, and patient-centered soft skills.

AI is offering new ways to support pharmacists' decision-making and patient care.

Community pharmacies can enhance medication safety by proactively identifying risks and implementing targeted best practices.

Sally Arif, PharmD, BCCP, discusses her presentation on the critical role of pharmacists in addressing health disparities by improving communication, fostering cultural competence, and promoting pharmacoequity.

After decades without improvements, an expert with Baptist Health described the small cell lung cancer (SCLC) space as “exciting” following multiple innovations in the past few years.

A panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.

Panelists discuss how antibody-drug conjugates (ADCs) often cause toxic adverse events (AEs). Supportive care includes antiemetics, corticosteroids, and growth factors. Infusion reactions are managed with premedication and slow titration.

Panelists discuss how health care professionals support medication adherence through personalized strategies, communication, and technological aids, while evaluating menopause therapy effectiveness via regular assessments, standardized tools, and comprehensive patient-centered approaches.

Panelists note how medical professionals discuss menopause therapy, addressing symptoms, treatment options, safety concerns, adverse events, and personalized management strategies through patient-centered care. Professionals prioritize transparent communication, comprehensive risk assessment, and collaborative decision-making to ensure patient comfort and optimal management of menopausal transition.

Panelists discuss how antibody-drug conjugates (ADCs) often show more diverse outcomes in real-world settings compared with clinical trials, with varying efficacy and adverse effect profiles. Key practical considerations for pharmacists include appropriate dosing based on patient factors, managing drug interactions, implementing premedication protocols to minimize adverse reactions, and providing comprehensive supportive care. Careful monitoring and individualized patient management are essential for optimal therapeutic outcomes.